Analytics for Life, Inc.

Analytics for Life, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on April 5, 2024 and the most recent on April 5, 2024 (CorVista System with PH Add-On). Its most common review panel is Cardiovascular (1 device).